Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance

BACKGROUND: Treating drug-resistant sarcomas remains a major challenge. The present study aimed to identify a novel therapy for drug-resistant sarcomas based on metabolic errors involving argininosuccinate synthetase1 (ASS1). RESULTS: ASS1 expression was reduced in Dox-resistant sarcoma cells. Immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Youngji, Kobayashi, Eisuke, Kubota, Daisuke, Suehara, Yoshiyuki, Mukaihara, Kenta, Akaike, Keisuke, Ito, Ayumu, Kaneko, Kazuo, Chuman, Hirokazu, Kawai, Akira, Kitano, Shigehisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342592/
https://www.ncbi.nlm.nih.gov/pubmed/27683125
http://dx.doi.org/10.18632/oncotarget.12225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342592/
https://www.ncbi.nlm.nih.gov/pubmed/27683125
http://dx.doi.org/10.18632/oncotarget.12225

Ejemplares similares